CrossrefInfokarte
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials
Rheumatology and Therapy · 2024-06 · 11 (3) · 737-753
DOI: 10.1007/s40744-024-00671-4 ↗Abstract
Kein Abstract verfügbar.
EUVIMED